Literature DB >> 11459228

Differential tyrosine phosphorylation of phospholipase D isozymes by hydrogen peroxide and the epidermal growth factor in A431 epidermoid carcinoma cells.

D S Min1, B H Ahn, Y H Jo.   

Abstract

The regulatory mechanism through which the phospholipase D (PLD) isoforms PLD1 and PLD2 are activated is poorly understood. We investigated the possibility that the PLD isozymes are differentially regulated in response to pharmacologic stimulants in cells. In this report, we demonstrate for the first time that H2O2 and EGF differentially induce tyrosine phosphorylation of the PLD isozymes in A431 cells, which express both PLD1 and PLD2. H2O2 induced tyrosine phosphorylation of PLD1 and PLD2, whereas EGF only caused the tyrosine phosphorylation of PLD2. Both agents also induced phosphorylation of the EGF receptor. Interestingly, the PLD isozymes were associated with the EGF receptor and PKC-alpha in a ligand independent manner. Activation of PLD by H2O2 and EGF nearly correlated with tyrosine phosphorylation of the protein in PLD1 immune complexes. Activation of PLD by both agents was inhibited by the PKC inhibitor, Ro 31-8220, and by the down-regulation of PKC. Pretreatment of the cells with the tyrosine kinase inhibitor tyrphostin AG1478 resulted in inhibition of the H2O2 and EGF-induced tyrosine phosphorylation and PLD activation. These results indicate that H2O2 and EGF induce differential tyrosine phosphorylation of PLD isozymes. Also, the activation of PLD by these agonists involves tyrosine phosphorylation and PKC activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459228

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  10 in total

1.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 2.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

4.  CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

Authors:  A Pupovac; L Stokes; R Sluyter
Journal:  Purinergic Signal       Date:  2013-06-21       Impact factor: 3.765

5.  Transmodulation between phospholipase D and c-Src enhances cell proliferation.

Authors:  Bong-Hyun Ahn; Shi Yeon Kim; Eun Hee Kim; Kyeong Sook Choi; Taeg Kyu Kwon; Young Han Lee; Jong-Soo Chang; Myung-Suk Kim; Yang-Hyeok Jo; Do Sik Min
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 6.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 7.  New concepts in phospholipase D signaling in inflammation and cancer.

Authors:  Julian Gomez-Cambronero
Journal:  ScientificWorldJournal       Date:  2010-07-07

8.  AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma.

Authors:  Xiaoyong Wang; Chengjun Tao; Chengda Yuan; Jinping Ren; Ming Yang; Hangyu Ying
Journal:  Mol Med Rep       Date:  2017-06-23       Impact factor: 2.952

Review 9.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

10.  Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice.

Authors:  H Y Lee; K Yea; J Kim; B D Lee; Y C Chae; H S Kim; D-W Lee; S-H Kim; J-H Cho; C J Jin; D-S Koh; K S Park; P-G Suh; S H Ryu
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.